| Factor Information | |
|---|---|
| Data ID | 847 |
| Factor | Arrhythmia |
| Description | Disease of the systemic atrioventricular valve (SAVV) is particularly important, given that regurgitation of that valve leads to ventricular dysfunction, arrhythmias, and ultimately heart failure and death. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | We assessed midterm outcomes and prognostic factors in ACHD undergoing SAVV surgery |
| p Value | 0.04 |
| Conclusion | Preoperative arrhythmias were common occurring in 71% of the patients with ccTGA but less common in either the patients with AVSD or congenital MR/MS. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 488 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ccTGA/MS, MR |
| Reference | |
|---|---|
| PMID | 28520541 |
| Year | 2017 |
| Title | Outcomes and Prognostic Factors for Adult Patients With Congenital Heart Disease Undergoing Primary or Reoperative Systemic Atrioventricular Valve Surgery. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | retrospective cohort study | |
| Region | New York, USA | |
| Method | retrospective evaluation | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | SAVV surgery | |
| Group | ccTGA(Treatment) | Congenital MS/MR(Control) |
| Number | 10(total:14) | 6(total:14) |
| Age | 39.1 ± 15.4 years | 36.7 ± 11.4 years |
| Gender (Male: Female) | 7:7 (total) | 8:6 (total) |
| Marker Level | 0.71 | 0.43 |
